Bibliotecas PUC-SP - Busca Integrada

Gefitinib in elderly and unfit patients affected by advanced non-small-cell lung cancer

von Gridelli, C, Maione, P, Castaldo, V, Rossi, A
Veröffentlicht 2003

nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial

von Gridelli C, Chen T, Ko A, O'Brien ME, Ong TJ, Socinski MA, Postmus PE
Veröffentlicht in Drug Design, Development and Therapy (2018-05-01)

Lessons from the ‘Iressa’ Expanded Access Programme: gefitinib in special non-small-cell lung cancer patient populations

von Stahel, R, Rossi, A, Petruzelka, L, Kosimidis, P, de Braud, F, Bernardo, M M, Souquet, P-J, Parra, H Soto, Gridelli, C
Veröffentlicht 2003

Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 study

von Gridelli, C, Manzione, L, Perrone, F, Veltri, E, Cioffi, R, Caprio, M Grazia, Frontini, L, Rossi, A, Barletta, E, Barzelloni, M L, Bilancia, D, Gallo, C
Veröffentlicht 2001

Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses

von Gridelli, C, Frontini, L, Perrone, F, Gallo, C, Gulisano, M, Cigolari, S, Castiglione, F, Robbiati, S F, Gasparini, G, Ianniello, G P, Farris, A, Locatelli, M C, Felletti, R, Piazza, E
Veröffentlicht 2000

Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer

von Ciardiello, F, Troiani, T, Caputo, F, De Laurentiis, M, Tortora, G, Palmieri, G, De Vita, F, Diadema, M R, Orditura, M, Colantuoni, G, Gridelli, C, Catalano, G, De Placido, S, Bianco, A R
Veröffentlicht 2006

nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy

von Thomas M, Spigel DR, Jotte RM, McCleod M, Socinski MA, Page RD, Gressot L, Knoble J, Juan O, Morgensztern D, Isla D, Kim ES, West H, Ko A, Ong TJ, Trunova N, Gridelli C
Veröffentlicht in Lung Cancer: Targets and Therapy (2017-10-01)

A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study

von Gridelli, C, Gallo, C, Di Maio, M, Barletta, E, Illiano, A, Maione, P, Salvagni, S, Piantedosi, F V, Palazzolo, G, Caffo, O, Ceribelli, A, Falcone, A, Mazzanti, P, Brancaccio, L, Capuano, M A, Isa, L, Barbera, S, Perrone, F
Veröffentlicht 2004

Supportive care in patients with advanced non-small-cell lung cancer

von Di Maio, M, Perrone, F, Gallo, C, Iaffaioli, R V, Manzione, L, Piantedosi, F V, Cigolari, S, Illiano, A, Barbera, S, Robbiati, S F, Piazza, E, Ianniello, G P, Frontini, L, Veltri, E, Castiglione, F, Rosetti, F, De Maio, E, Maione, P, Gridelli, C
Veröffentlicht 2003

Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer

von Di Maio, M, Gridelli, C, Gallo, C, Manzione, L, Brancaccio, L, Barbera, S, Robbiati, S F, Ianniello, G P, Ferraù, F, Piazza, E, Frontini, L, Rosetti, F, Carrozza, F, Bearz, A, Spatafora, M, Adamo, V, Isa, L, Iaffaioli, R V, Di Salvo, E, Perrone, F
Veröffentlicht 2004